Israel Englander’s Terns Pharmaceuticals TERN Stock Holding History

Israel Englander’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-381,800	Closed	-$20.1M	–	6395
2026 Q1	$20.1M	Buy	+381,800	New	+$15.7M	0.01%	1546
2024 Q4	–	Sell	-50,000	Closed	-$417K	–	6456
2024 Q3	$417K	Hold	50,000	–	–	﹤0.01%	4971
2024 Q2	$341K	Buy	50,000 +33,700	+207%	+$204K	﹤0.01%	4834
2024 Q1	$107K	Sell	16,300 -33,700	-67%	-$220K	﹤0.01%	5559
2023 Q4	$325K	Buy	+50,000	New	+$264K	﹤0.01%	4923

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Israel Englander's TERN Position: Q2 2026 in Review

Israel Englander sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 3,011,558 shares — an estimated $159M sold.

Israel Englander first reported a position in TERN in Q2 2021 and held it in 19 quarters. The position peaked at $159M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Israel Englander reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 3,011,558 Terns Pharmaceuticals shares in Q2 2026, an estimated $159M.
Israel Englander first reported a position in Terns Pharmaceuticals in Q2 2021 and held it in 19 quarters.
Israel Englander's Terns Pharmaceuticals position peaked at $159M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.